| 5.905 -0.075 (-1.25%) | 12-15 15:59 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 7.35  |
1-year : | 8.1 |
| Resists | First : | 6.29 |
Second : | 6.94 |
| Pivot price | 6.34 |
|||
| Supports | First : | 5.26 | Second : | 4.37 |
| MAs | MA(5) : | 6.28 |
MA(20) : | 6.15 |
| MA(100) : | 6.95 |
MA(250) : | 0 | |
| MACD | MACD : | -0.2 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 39.1 |
D(3) : | 59.7 |
| RSI | RSI(14): 38.3 |
|||
| 52-week | High : | 9.34 | Low : | 1.91 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ MASS ] has closed above bottom band by 4.0%. Bollinger Bands are 51.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 6.05 - 6.1 | 6.1 - 6.13 |
| Low: | 5.63 - 5.68 | 5.68 - 5.72 |
| Close: | 5.83 - 5.92 | 5.92 - 5.97 |
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Wed, 12 Nov 2025
Some 908 Devices Inc. (NASDAQ:MASS) Shareholders Look For Exit As Shares Take 26% Pounding - simplywall.st
Tue, 11 Nov 2025
908 Devices Loses US$55m Market Value But Insiders See Windfall Of US$82k - Sahm
Mon, 10 Nov 2025
Earnings call transcript: 908 Devices reports Q3 2025 revenue growth amid EPS miss - Investing.com
Mon, 10 Nov 2025
908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook - Business Wire
Fri, 07 Nov 2025
What To Expect From 908 Devices Inc (MASS) Q3 2025 Earnings - Yahoo Finance
Thu, 30 Oct 2025
908 Devices to Participate in Upcoming Investor Conferences - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 36 (M) |
| Shares Float | 22 (M) |
| Held by Insiders | 8.3 (%) |
| Held by Institutions | 90.3 (%) |
| Shares Short | 2,790 (K) |
| Shares Short P.Month | 1,950 (K) |
| EPS | -2.07 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.76 |
| Profit Margin | -6.4 % |
| Operating Margin | -40.1 % |
| Return on Assets (ttm) | -16.5 % |
| Return on Equity (ttm) | -54.5 % |
| Qtrly Rev. Growth | -3.5 % |
| Gross Profit (p.s.) | 0.87 |
| Sales Per Share | 1.79 |
| EBITDA (p.s.) | -1.21 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -27 (M) |
| Levered Free Cash Flow | 8 (M) |
| PE Ratio | -2.86 |
| PEG Ratio | 0 |
| Price to Book value | 1.56 |
| Price to Sales | 3.28 |
| Price to Cash Flow | -7.85 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|